A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination.

Manaa, Amir; Ziv, Michael; Krausz, Judit; Dodiuk-Gad, Roni P

Manaa, Amir; Ziv, Michael; Krausz, Judit; Dodiuk-Gad, Roni P.

Manaa A; Department of Dermatology, Emek Medical Center, Afula, Israel.
Ziv M; Department of Dermatology, Emek Medical Center, Afula, Israel.
Krausz J; Department of Pathology, Emek Medical Center, Afula, Israel.
Dodiuk-Gad RP; Department of Dermatology, Emek Medical Center, Afula, Israel.

Dermatol Ther ; 35(7): e15546, 2022 07.

Article in English | MEDLINE | ID: covidwho-1932432

Subject(s)

COVID-19; Drug Eruptions; Exanthema; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Drug Eruptions/diagnosis; Drug Eruptions/etiology; Exanthema/chemically induced; Exanthema/diagnosis; Humans; Vaccination

Keywords

COVID-19; SARS-COV-2; drug reaction; symmetrical drug-related intertriginous flexural exanthema; vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Eruptions / Exanthema / COVID-19 Type of study: Case report / Diagnostic study / Observational study Topics: Vaccines Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Dth.15546

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google